Abstract
Introduction

36
Microencapsulation of biomolecules has become a challenging approach to design new 37 materials used in food and pharmaceutical industries to improve stability, delivery and to 38 control the release of encapsulated species. The preparation of enzyme microcapsules 39 requires extremely well controlled conditions, for example the encapsulating agent should 40 provide a suitable environment for the microencapsulation of bioactive compound 41 High purity reagents were used in all the experiments. 120
Chitosan of medium molecular weight, with a Brookfield viscosity of 200 mPa.s (1wt% 121 in 1% acetic acid; 25ºC) (448877-250g) was purchased from Aldrich (Germany). Water 122 soluble chitosan (pharmaceutical grade water soluble chitosan) was obtained from China 123
Eastar Group (Dong Chen) Co., Ltd ((Batch no. SH20091010). Water soluble chitosan 124 was produced by carboxylation and had a deacetylation degree of 96.5% and a viscosity 125 of 5 mPa.s (1%; 25 ºC). Sodium alginate (alginic acid, sodium salt) (180947-100g) was 126 from Aldrich (USA) and the calcium alginate was prepared from sodium alginate with 127 calcium chloride (F1435283624 -1.02083.1000) from Merck (Darmstadt, Germany). 128 soluble chitosan 1% (m/V), sodium alginate 1% (w/V) and Arabic gum 1% (w/V) were 136 prepared with deionised water and with 2 hours agitation at 1200 rpm. Calcium alginate 137 solution was prepared from a sodium alginate solution (1% (w/V)) adding a calcium 138 chloride solution with the concentration of 1% (w/V). 139 β-galactosidase enzyme (Escherichia coli) from Calbiochem (Cat 345,788 ; EC number: 140 3.2.1.23) with a specific activity = 955 U/mg protein and BSA (bovine serum albumin) 141 purchased from Sigma Aldrich (A7906-100g) were used in the preparation of the enzyme 142 solution. A stock solution composed by β-galactosidase (0.1 mg/ml) and BSA (1 mg/ml) 143 was prepared using a 0.08 M phosphate buffer at pH 7.7. BSA is used to stabilize enzymes 144 and to prevent termodegradation, adhesion of the enzyme to reaction tubes, pipet tips, and 145 other vessels (Chang & Mahoney, 1995) . 146 147 The size distribution of the microparticles was assessed by laser granulometry using a 170
Experimental conditions -Spray-drying process
Results and Discussion
208
The microencapsulation process has been performed in order to obtain microparticles 209 with different formulations. With a product yield (quantity of powder recovered reported 210 to the quantity of raw materials used) ranging from 36 to 59% (arabic gum -56%, 211 chitosan -48%, modified chitosan -59%, calcium alginate -36%, sodium alginate -212 37%), the prepared microparticles were characterized and the enzymatic activity was 213 The stability of many colloidal systems is directly related to the magnitude of their zeta 237 potential. In general, if the value of the particle´s zeta potential is large (positive or 238 negative), the colloidal system will be stable. Commonly it is accepted that a zeta 239 potential higher than 30-40 mV (negative or positive) is indicative of a stable colloidal 240 system. Conversely, if the particle´s zeta potential is relatively small, the colloid system 241 will tend to agglomerate. Table 2 shows zeta potential values measured in water for the 242 microparticles formed with different biopolymers. The value of the zeta potential 243 increases in the following order: arabic gum, chitosan, modified chitosan, calcium 244 alginate and finally sodium alginate. Therefore, the more stable systems are obtained with 245 the sodium alginate particles. If one compares the values of zeta potential with and 246 without enzyme, it seems that the behaviour is not the same for the different biopolymers. 247 Neverthless these differences are not significant as Table 2 shows. In all the cases, the 248 value obtained is associated to a stable colloidal system. 249 Menten parameters (Fig. 4) . The fitting of the experimental data to the Lineweaver-Burk 294 representation shows high correlation coefficients (>0.97) for all the enzyme 295 formulations. The Michaelis-Menten parameters were determined for the 4 biopolymers 296 and are presented in Table 3 . 297
The Vmax parameter, representing the maximum reaction rate at a given enzyme 298
concentration, decreased after immobilization thus confirming what was observed by 299
Haider & Husain (2009). Some active centers are likely to be blocked after 300 immobilization, which reduces the reaction rate, causing the decrease of the maximum 301 reaction velocity. This decrease is more significant in the cases of the assays with sodium 302 alginate and modified chitosan. The enzyme microparticles formed with arabic gum had 303 the smallest decrease of Vmax. On the other hand, calcium alginate has a Vmax almost 304 two times higher than the sodium alginate. 
Conclusion
322
The present work demonstrates that microencapsulation of the β-galactosidase enzyme 323 using different biopolymers by a spray-drying technique is possible. 324
Differences on the morphology and size of the enzyme microparticles have been 325 observed. The microcapsules produced were spherical and had a mean diameter around 3 326 µm, for all the biopolymers tested. In the case of the particles formed with chitosan or 327 arabic gum the surface was very rough; on the other hand, the particles formed with 328 calcium or sodium alginate or modified chitosan presented a very smooth surface. The
The type of biopolymer used induces the type of microparticles, shell resistance, which 331 affects the diffusion of substrate and products to and from the microparticle. Kinetic data 332
show differences on β-galactosidase activity after encapsulation, depending on the type 333 of matrix used. The enzyme microparticles formed with arabic gum presented the 334 smallest decrease of enzyme activity, followed by the calcium alginate, sodium alginate 335 and modified chitosan. 
